Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
One possible explanation is that your body is undergoing an adjustment period
However, in the pivotal Phase IIb trial, it failed to demonstrate statistically significant weight loss compared to placebo at the primary endpoint, leading the developer (Metabolic Pharmaceuticals Ltd.) to terminate the commercial program
refrigerated storage required Safety Profile: Well-tolerated in 900+ participants with minimal adverse effects Important: Sold for research purposes only
Understanding anxiety-related side effects of GLP-1 medications provides additional context for people managing mental health alongside weight loss
The compound's development represents years of medicinal chemistry optimization, resulting in a 10-fold improvement in potency over parent compounds while maintaining excellent safety margins in preclinical studies
US$ 27.41
US$ 22.70
US$ 20.87
US$ 29.44
US$ 23.30
